Prothena Corporation plc
Prothena Corporation plc (PRTA) Revenue
Annual & quarterly revenue history · segment & region breakdown
PRTA · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsProthena Corporation plc trailing twelve-month (TTM) revenue is $0.06B, a decrease of 92.83% year-over-year from $0.01B in FY2025.
Revenue trend
2025 – 2010 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.01B | -$0.13B | -92.83% |
| 2024-12-31 | $0.14B | +$0.04B | +47.92% |
| 2023-12-31 | $0.09B | +$0.04B | +69.50% |
| 2022-12-31 | $0.05B | -$0.15B | -73.13% |
| 2021-12-31 | $0.20B | +$0.20B | +23414.30% |
| 2020-12-31 | $0.00B | +$0.00B | +4.79% |
| 2019-12-31 | $0.00B | -$0.00B | -14.76% |
| 2018-12-31 | $0.00B | -$0.03B | -96.53% |
| 2017-12-31 | $0.03B | +$0.03B | +2508.44% |
| 2016-12-31 | $0.00B | -$0.00B | -34.35% |
Compare revenue vs peers
BiotechnologyCompare PRTA revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Prothena Corporation plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Prothena Corporation plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Prothena Corporation plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PRTA revenue · 4 questionsPRTA's trailing twelve-month (TTM) revenue is $0.06B. That is a decrease of 92.83% year-over-year from $0.01B in FY2025.
▸ Source: FMP · Prothena Corporation plc SEC filings · GAAP · Prothena Corporation plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026